Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.avsg.2020.07.013 http://scihub22266oqcxt.onion/10.1016/j.avsg.2020.07.013 32736027!7386281!32736027     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Vasc+Surg 2020 ; 69 (ä): 85-88 Nephropedia Template TP {{tp|p=32736027|t=2020. Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19 |pdf=|usr=}}{{32736027}} gab.com Text Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19 JO: Ann Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=32736027 #FOAvip INTRODUCTION: Few cases of arterial thromboembolisms have been reported after novel coronavirus disease 2019 (COVID-19) in case of severe infection or in elderly patients. We report a case of femoral arterial thrombosis in a young patient after nonsevere infection. CASE DESCRIPTION: A common femoral artery thrombosis extended in the first third of superficial and profunda femoral arteries associated with tibial posterior and popliteal artery thrombosis was diagnosed in a 24-year-old man complaining of right lower limb pain for one month. The evolution was good after anticoagulation and antiaggregant treatments and thrombectomy. Etiologic assessment was negative except for nonsevere COVID-19. DISCUSSION: COVID-19 accesses host cells via angiotensin-converting enzyme 2 protein, abundant in the lungs, which is also expressed by endothelial cells and is associated with important inflammatory syndrome and coagulopathy, leading to vascular lesions. Thrombosis prevalence is not fully established and seems to be higher in case of major inflammation and in the intensive care unit (ICU). Arterial thromboembolisms are described in many vascular territories, each time in elderly patients, or in case of severe infection. We described a femoral arterial thrombosis in a young patient with negative etiological assessment except nonsevere COVID-19. Treatment consists in anticoagulation and antiaggregant drugs and thrombectomy. Preventing venous thromboembolism treatment is recommended in case of severe infection or in the ICU, but there is no clear recommendation for arterial thromboembolism prevention. This case should lead us to be very careful of the arterial event risk even if the infection is nonsevere and the patient is young. Twit Text FOAVip Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19 ????Ann Vasc Surg http://www.kidney.de/pget.php?&tw=1&pmid=32736027 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32736027 #FOAvip English Wikipedia <ref>{{Cite pmid|32736027}}</ref> Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19 #MMPMID32736027 Veyre F; Poulain-Veyre C; Esparcieux A; Monsarrat N; Aouifi A; Lapeze J; Chatelard P Ann Vasc Surg 2020[Nov]; 69 (ä): 85-88 PMID32736027show ga INTRODUCTION: Few cases of arterial thromboembolisms have been reported after novel coronavirus disease 2019 (COVID-19) in case of severe infection or in elderly patients. We report a case of femoral arterial thrombosis in a young patient after nonsevere infection. CASE DESCRIPTION: A common femoral artery thrombosis extended in the first third of superficial and profunda femoral arteries associated with tibial posterior and popliteal artery thrombosis was diagnosed in a 24-year-old man complaining of right lower limb pain for one month. The evolution was good after anticoagulation and antiaggregant treatments and thrombectomy. Etiologic assessment was negative except for nonsevere COVID-19. DISCUSSION: COVID-19 accesses host cells via angiotensin-converting enzyme 2 protein, abundant in the lungs, which is also expressed by endothelial cells and is associated with important inflammatory syndrome and coagulopathy, leading to vascular lesions. Thrombosis prevalence is not fully established and seems to be higher in case of major inflammation and in the intensive care unit (ICU). Arterial thromboembolisms are described in many vascular territories, each time in elderly patients, or in case of severe infection. We described a femoral arterial thrombosis in a young patient with negative etiological assessment except nonsevere COVID-19. Treatment consists in anticoagulation and antiaggregant drugs and thrombectomy. Preventing venous thromboembolism treatment is recommended in case of severe infection or in the ICU, but there is no clear recommendation for arterial thromboembolism prevention. This case should lead us to be very careful of the arterial event risk even if the infection is nonsevere and the patient is young. |*Femoral Artery[MESH] |Anticoagulants/therapeutic use[MESH] |Arterial Occlusive Diseases/therapy/*virology[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Combined Modality Therapy[MESH] |Coronavirus Infections/*complications[MESH] |Diagnosis, Differential[MESH] |Humans[MESH] |Male[MESH] |Pandemics[MESH] |Platelet Aggregation Inhibitors/therapeutic use[MESH] |Pneumonia, Viral/*complications[MESH] |SARS-CoV-2[MESH] |Thrombectomy[MESH] |Thrombosis/drug therapy/*virology[MESH]Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19 (epmc).pdf DeepDyve Pubget Overpricing